Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_assertion type Assertion NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_head.
- NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_assertion description "[Recent studies have indicated that the loss of p16, an inhibitor of CDK4, promotes the acquisition of malignant characteristics in gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_provenance.
- NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_assertion evidence source_evidence_literature NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_provenance.
- NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_assertion SIO_000772 17273768 NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_provenance.
- NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_assertion wasDerivedFrom befree-2016 NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_provenance.
- NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_assertion wasGeneratedBy ECO_0000203 NP592014.RAdK0D1KQ89RZZKrhSGCG5dX9v1ixNlUhBno2SchtwWSs130_provenance.